Literature DB >> 10658675

Leukemic cells from murine myeloid leukemia display an intrinsic ability for autonomous proliferation.

D J Curtis1, D Metcalf, B Alexander, C G Begley.   

Abstract

OBJECTIVE: Human acute myeloid leukemia (AML) cells can proliferate in vitro in the absence of added growth factors when cultured at high cell density. Autocrine growth factor production is a postulated mechanism of autonomous growth. We sought to examine this using murine AML cells.
MATERIALS AND METHODS: We have utilized a Moloney murine leukemia virus (M-MuLV) model of AML to investigate the nature of autonomous in vitro growth of myeloid leukemic cells.
RESULTS: Like human AML, M-MuLV-induced myeloid leukemic cells displayed autonomous growth in unstimulated high cell density cultures. However, replating of individual, primary, growth factor autonomous colonies of leukemic cells demonstrated the presence of clonogenic cells capable of autonomous growth when cultured at low cell density. In addition, there was heterogeneity in the progeny of these cells: both factor-dependent leukemic cells and cells autonomous of exogenous factor were observed.
CONCLUSION: We propose that clonogenic cells capable of autonomous growth at low cell density represent leukemic progenitors while the majority of leukemic cells derived from these "autonomous" leukemic cells are factor-dependent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658675     DOI: 10.1016/s0301-472x(99)00123-x

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  2 in total

1.  Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.

Authors:  T Sato; T Maekawa; S Watanabe; K Tsuji; T Nakahata
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy.

Authors:  Kathleen M Sakamoto; David A Frank
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.